Drug Type Small molecule drug |
Synonyms 274150, GSK 274150, GW 274150 + [1] |
Target |
Action inhibitors |
Mechanism NOS2 inhibitors(Nitric oxide synthase, inducible inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC8H17N3O2S |
InChIKeyMOLOJNHYNHBPCW-ZETCQYMHSA-N |
CAS Registry210354-22-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute migraine | Phase 2 | Australia | 01 Dec 2005 | |
Acute migraine | Phase 2 | New Zealand | 01 Dec 2005 | |
Headache | Phase 2 | Australia | 01 Dec 2005 | |
Headache | Phase 2 | New Zealand | 01 Dec 2005 | |
Migraine Without Aura | Phase 2 | Belgium | 01 Oct 2005 | |
Migraine Without Aura | Phase 2 | Denmark | 01 Oct 2005 | |
Migraine Without Aura | Phase 2 | Finland | 01 Oct 2005 | |
Migraine Without Aura | Phase 2 | France | 01 Oct 2005 | |
Migraine Without Aura | Phase 2 | Germany | 01 Oct 2005 | |
Migraine Without Aura | Phase 2 | Italy | 01 Oct 2005 |